These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16211296

  • 21. [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells].
    Fukuchi M, Mineura K, Kowada M, Terashima I, Kohda K.
    No To Shinkei; 1997 Jun; 49(6):521-8. PubMed ID: 9198092
    [Abstract] [Full Text] [Related]

  • 22. [Relationship between the expression of O6-methylguanine-DNA methyltransferase in glioma and the survival time of patients].
    Sun YH, Zhang YZ, Wang ZC, Sun MZ, Zhao DH.
    Ai Zheng; 2004 Sep; 23(9):1052-5. PubMed ID: 15363200
    [Abstract] [Full Text] [Related]

  • 23. In situ detection of O6-methylguanine-DNA methyltransferase messenger RNA in paraffin-embedded human astrocytic tumor tissues by nested in situ RT-PCR is useful in predicting chemotherapy-resistance of tumors.
    Ohe N, Saio M, Kijima M, Tamakawa N, Suwa T, Kojima Y, Yano H, Kaku Y, Iwama T, Shinoda J, Sakai N, Takami T.
    Int J Oncol; 2003 Mar; 22(3):543-9. PubMed ID: 12579307
    [Abstract] [Full Text] [Related]

  • 24. [Study on MGMT assay and tumor individual predictable chemotherapy].
    Zhang YP.
    Ai Zheng; 2004 Jun; 23(6):724-34. PubMed ID: 15191682
    [Abstract] [Full Text] [Related]

  • 25. Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas.
    Nakagawa T, Ido K, Sakuma T, Takeuchi H, Sato K, Kubota T.
    Neuropathology; 2009 Aug; 29(4):379-88. PubMed ID: 19019175
    [Abstract] [Full Text] [Related]

  • 26. The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea(ACNU) in gallbladder carcinoma cells.
    Sato K, Kitajima Y, Koga Y, Miyazaki K.
    Anticancer Res; 2005 Aug; 25(6B):4021-8. PubMed ID: 16309194
    [Abstract] [Full Text] [Related]

  • 27. Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-resistant C6 rat glioma cells.
    Nakagawa T, Kubota T, Ido K, Sakuma T, Matsuda K.
    J Neurooncol; 2006 Sep; 79(3):271-9. PubMed ID: 16645721
    [Abstract] [Full Text] [Related]

  • 28. [Chemotherapy for gliomas based on the expression levels of drug resistant genes].
    Matsumoto Y, Morisaki K, Miyake K, Kawanishi M, Kawai N, Ogawa T, Irie K, Kunishio K, Nagao S.
    No Shinkei Geka; 2001 Jul; 29(7):625-30. PubMed ID: 11517503
    [Abstract] [Full Text] [Related]

  • 29. Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase pi in glioblastoma and the survival of the patients treated with nimustine hydrochloride: an immunohistochemical analysis.
    Anda T, Shabani HK, Tsunoda K, Tokunaga Y, Kaminogo M, Shibata S, Hayashi T, Iseki M.
    Neurol Res; 2003 Apr; 25(3):241-8. PubMed ID: 12739231
    [Abstract] [Full Text] [Related]

  • 30. Alterations in S-adenosylhomocysteine metabolism decrease O6-methylguanine DNA methyltransferase gene expression without affecting promoter methylation.
    Hermes M, Geisler H, Osswald H, Riehle R, Kloor D.
    Biochem Pharmacol; 2008 Jun 01; 75(11):2100-11. PubMed ID: 18395186
    [Abstract] [Full Text] [Related]

  • 31. [Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases].
    Zhang JP, Shi HL, Sai K, Yue WY, Mu YG, Zhang XH, Chen ZP.
    Ai Zheng; 2006 Dec 01; 25(12):1533-7. PubMed ID: 17166381
    [Abstract] [Full Text] [Related]

  • 32. [Anti-tumor activity of ACNU against malignant glioma--a clinical application of in vitro sensitivity test of chemotherapeutic agent].
    Shibuya N, Yoshida J, Kobayashi T, Kageyama N.
    No Shinkei Geka; 1983 Apr 01; 11(4):361-7. PubMed ID: 6306497
    [Abstract] [Full Text] [Related]

  • 33. [Chemotherapeutic strategy in rat brain tumor cells resistant to ACNU using an in vitro colony formation assay].
    Mineura K, Sasaki J, Fushimi S, Sasajima H, Ishino Y, Kowada M.
    No To Shinkei; 1989 Sep 01; 41(9):927-32. PubMed ID: 2590562
    [Abstract] [Full Text] [Related]

  • 34. Protective effect of O6-methylguanine-DNA-methyltransferase on mammalian cells.
    Li DB, Wang JS, Fang Q, Sun HY, Xu W, Li WD.
    Chin Med J (Engl); 2007 Apr 20; 120(8):714-7. PubMed ID: 17517190
    [Abstract] [Full Text] [Related]

  • 35. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R.
    Clin Cancer Res; 1996 Nov 20; 2(11):1829-35. PubMed ID: 9816137
    [Abstract] [Full Text] [Related]

  • 36. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
    Batista LF, Roos WP, Christmann M, Menck CF, Kaina B.
    Cancer Res; 2007 Dec 15; 67(24):11886-95. PubMed ID: 18089819
    [Abstract] [Full Text] [Related]

  • 37. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
    Dederer LIu, Sokolova IS, Bakhmedova AA, Miniker TD, Mel'nik SIa, Gorbacheva LB.
    Biokhimiia; 1995 Sep 15; 60(9):1521-9. PubMed ID: 8562657
    [Abstract] [Full Text] [Related]

  • 38. Extraneuronal monoamine transporter expression and DNA repair vis-à-vis 2-chloroethyl-3-sarcosinamide-1-nitrosourea cytotoxicity in human tumor cell lines.
    Chen ZP, Remack J, Brent TP, Mohr G, Panasci LC.
    Clin Cancer Res; 1999 Dec 15; 5(12):4186-90. PubMed ID: 10632359
    [Abstract] [Full Text] [Related]

  • 39. A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
    Cornetta K, Croop J, Dropcho E, Abonour R, Kieran MW, Kreissman S, Reeves L, Erickson LC, Williams DA.
    Cancer Gene Ther; 2006 Sep 15; 13(9):886-95. PubMed ID: 16645619
    [Abstract] [Full Text] [Related]

  • 40. O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells.
    Blough MD, Zlatescu MC, Cairncross JG.
    Cancer Res; 2007 Jan 15; 67(2):580-4. PubMed ID: 17234766
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.